WIB GER Week ended 07 Aug 2026

Weekly Investor Report

Wienerberger AG · Basic Materials · Building Materials

Open interactive chart View report data
Latest close 21.74 EUR
2.0% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -10.0% below the Trend Line and sits at 15.2% of its 52-week range. The latest completed week returned 2.0%, after a -2.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 45/100. Near-term considerations: volume confirmation is below normal.

Setup score 18 out of 100
Latest Close 21.74 EUR 7 Aug 2026
1W Return 2.0% latest completed week
4W Return -2.9% short-term follow-through
12W Return -3.0% quarterly tape
Trend Breadth 3.8% 2 of 52 weeks active
Volume Ratio 0.6x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.0% Latest completed week; four-week move -2.9%. Indicator stack 2/0 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 45/100 7 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -10.0% below the Trend Line and sits at 15.2% of its 52-week range. The latest completed week returned 2.0%, after a -2.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0512-week average 0.06

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.05Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -2.9% over four weeks, -3.0% over 12 weeks, and -31.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W2.0%
4W-2.9%
12W-3.0%
26W-23.5%
52W-31.0%
Active trend streak0 weeks
Active weeks in one year2
Trend breadth3.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.46Latest activity-pressure read.
Pressure change-610.3%Four-week change in activity pressure.
Leadership-21.38Latest relative-leadership reading.
RS change-24.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 88%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength61/100Blend of value, momentum, and quality. Underlying universe rank 40; rank 1 is best.
Value86/100Relative valuation strength. Underlying universe rank 15; rank 1 is best.
Quality30/100Profitability and accounting quality. Underlying universe rank 71; rank 1 is best.
Momentum10/100Medium-term price momentum. Underlying universe rank 91; rank 1 is best.
Growth78/100Revenue and earnings growth. Underlying universe rank 23; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework44/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
18.0x
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
6.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
34.8%
Gross profit retained from each unit of revenue.
Operating margin
6.8%
Operating profit retained from revenue.
Free-cash-flow margin
5.2%
Free cash flow generated from revenue.
Return on invested capital
5.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
1.2%
Latest one-year revenue growth.
EPS growth
112.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
18.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
4.4%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
4.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment45/100

Weighted news tone is neutral across 7 relevant articles.

1 positive · 4 neutral · 2 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-32.1%Distance below the 52-week high.
13-week volatility4.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+9.9%Week of 10 Apr.
Worst week-12.5%Week of 24 Jul.
Latest week+2.0%Week of 7 Aug.

Shape of recent returns

Strong gains4
Modest gains10
Flat weeks0
Modest losses5
Sharp losses7
Recent vol4.9%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew3.3% / -4.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

IndustryDE Building Materials
4-week rank1 / 3
Group average-4.8%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership

Four-week leaders

WIB · GER-2.9%HLBN · GER-5.6%HEI · GER-6.0%
08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape14/100

Trend, activity pressure, participation, and risk combine to a 14/100 tape read.

 Indicator analysis16/100

Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.

Activity pressure 0.05; No reversal markers Factors47/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 85; Small Cap Core rank 13 SVQF44/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 211.0 of 375 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment45/100

Weighted news tone is neutral across 7 relevant articles.

Wienerberger AG Revenue Breakdown – HAN:WIB Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202621.74 EUR2.0%24.14 EUR26.95 EUR-0.46-21.387.6KOff
31 Jul 202621.32 EUR6.2%24.37 EUR26.96 EUR-0.39-21.5111.9KOff
24 Jul 202620.08 EUR-12.5%24.64 EUR27.00 EUR-0.23-25.0047.8KOff
17 Jul 202622.94 EUR2.4%24.93 EUR27.04 EUR-0.05-14.047.9KOff
10 Jul 202622.40 EUR-2.7%25.14 EUR27.06 EUR0.09-17.236.7KOff
3 Jul 202623.02 EUR-2.6%25.34 EUR27.08 EUR0.18-17.74808Off
26 Jun 202623.64 EUR-0.8%25.52 EUR27.09 EUR0.16-12.232.1KOff
19 Jun 202623.82 EUR1.6%25.67 EUR27.10 EUR0.07-13.1910.0KOff
12 Jun 202623.44 EUR-1.8%25.76 EUR27.11 EUR-0.09-13.841.8KOff
5 Jun 202623.88 EUR-1.3%25.83 EUR27.12 EUR-0.12-13.19435Off
29 May 202624.20 EUR5.6%25.83 EUR27.13 EUR-0.12-13.7716.6KOff
22 May 202622.92 EUR2.2%25.85 EUR27.14 EUR-0.26-18.1022.3KOff
15 May 202622.42 EUR-7.6%25.95 EUR27.14 EUR-0.22-17.2840.7KOff
8 May 202624.27 EUR2.4%26.04 EUR27.16 EUR-0.18-12.4521.4KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context